Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 34,725 | 0.0% | 584,300 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 34,511 | 0.0% | 637,200 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 29,755 | 0.0% | 541,300 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 34,044 | 0.0% | 481,600 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 31,189 | 0.0% | 474,500 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 27,772 | 0.0% | 395,100 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 19,802 | 0.0% | 240,516 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 27,306 | 0.0% | 312,638 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 26,783 | 0.0% | 277,771 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 23,055 | 0.0% | 260,571 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 22,725 | 0.0% | 262,171 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 31,114 | 0.0% | 319,971 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 29,621 | 0.1% | 286,221 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 19,185 | 0.0% | 226,321 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 16,336 | 0.0% | 197,124 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 1,359 | 0.0% | 17,624 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 4,489 | 0.0% | 50,811 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 10,708 | 0.0% | 138,546 | 9/30/2021 |
| 2021 Q2 | 11/16/2021 | 11,560 | 0.0% | 138,546 | 6/30/2021 |
| 2021 Q1 | 8/16/2021 | 15,767 | 0.0% | 208,807 | 3/31/2021 |
| 2020 Q4 | 2/17/2021 | 5,347 | 0.0% | 60,980 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 5,459 | 0.0% | 71,757 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 30,400 | 0.1% | 246,474 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 18,472 | 0.0% | 218,603 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 26,232 | 0.1% | 310,254 | 12/31/2019 |
| 2014 Q1 | 5/9/2014 | 1,696 | 0.0% | 24,870 | 3/31/2014 |
| 2013 Q4 | 2/11/2014 | 5,044 | 0.0% | 71,700 | 12/31/2013 |